7:31 am Arrowhead Research receives regulatory approval to begin Phase 2a trial of chronic hepatitis B candidate ARC-520
View todays social media effects on ARWR
View the latest stocks trending across Twitter. Click to view dashboard
See who Arrowhead is hiring next, click here to view
